1/10/2007 | CV | Connetics holders can require company to buy back 2% convertibles
|
11/9/2006 | BT | RBC keeps Connetics at sector perform
|
11/9/2006 | BT | Connetics on hold by Jefferies
|
10/24/2006 | BT | Jefferies puts Connetics on hold
|
10/23/2006 | BT | Market Commentary: Connetics gains 46% on merger; Replidyne falls 45%, Forest down 6%; Adeza loses 16%; Amgen off
|
10/23/2006 | CV | Market Commentary: Connetics soars on buyout; Ford slips; FiberTower could see tough borrow; United Therapeutics plans deal
|
10/9/2006 | BT | Jefferies: CollaGenex, Forest Labs beat Q3 estimates; Connetics lags behind
|
9/20/2006 | BT | Connetics' Verdeso Foam gets FDA approval for atopic dermatitis
|
9/20/2006 | BT | Connetics reiterated at outperform by RBC
|
8/29/2006 | BT | Jefferies updates specialty pharmaceutical market
|
8/29/2006 | BT | RBC reiterates Connetics at outperform
|
8/28/2006 | BT | Connetics dermatitis foam shows positive results in phase 3 trial
|
8/16/2006 | BT | RBC Connetics outperform
|
8/16/2006 | BT | Connetics on hold by Jefferies
|
8/15/2006 | BT | Connetics at outperform by RBC
|
8/15/2006 | BT | Jefferies keeps Connetics at hold
|
8/15/2006 | BTCV | Connetics says inventory reduction will impact profitability for rest of year; posts $2.2 million Q2 net loss
|
8/1/2006 | BT | Connetics regains compliance with Nasdaq listing qualifications
|
7/26/2006 | BT | Connetics at outperform by RBC
|
7/25/2006 | BT | Market Commentary: Encysive plunges 40%; Momenta gains 38%; Nastech rises; Enzon up; Connetics firms
|
7/25/2006 | BTCVDD | Connetics files 10-Q to avoid further consent payments for 2.25% notes, acceleration of 2% notes
|
7/21/2006 | BTCV | Connetics receives consents to amend 2.25% convertibles but not for 2% convertibles
|
7/20/2006 | BT | RBC maintains Connetics at outperform
|
7/20/2006 | BT | Connetics on hold by Jefferies
|
7/20/2006 | BT | Market Commentary: Amgen weakens; Gilead off 3%; Alfacell falls 30%; Nektar up; Accentia lower; Connetics lifted
|
7/19/2006 | BTCV | Connetics extends, ups payment in consent solicitation for 2%, 2.25% convertibles
|
7/11/2006 | CV | Market Commentary: Archstone-Smith's reoffered deal gains on debut; Connetics steady on stock rebound; SanDisk recovers
|
7/11/2006 | BT | RBC upgrades Connetics to outperform
|
7/11/2006 | BT | Jefferies has Connetics on hold
|
7/11/2006 | BT | Market Commentary: Connetics stock regains 3%; Anadys adds 8% on new exec, moves Idenix, Vertex up, too; Xoma rises 5%
|
7/10/2006 | BT | Connetics expects second-quarter results below guidance, withdraws full-year estimates
|
7/10/2006 | BT | Market Commentary: Connetics drops 33% on lowered forecast; Antigenics off 5%; Depomed off; Acadia gains
|
7/10/2006 | BTCV | Connetics solicits consents for 2%, 2.25% convertibles
|
6/23/2006 | BT | SEC charges Massachusetts man with illegal trading on inside tip from drug executive
|
6/7/2006 | BT | Connetics gets sector perform rating from RBC
|
5/30/2006 | BTCVDD | Connetics in breach of convertible notes indentures following delayed filing of 10-Q
|
5/19/2006 | BT | Connetics faces possible Nasdaq delisting due to late filing of 10-Q
|
5/8/2006 | BT | Jefferies specialty pharmaceuticals report
|
5/4/2006 | BT | Jefferies maintains Connetics at hold
|
4/7/2006 | BT | Connetics fires employee accused of insider trading as SEC investigation continues
|
4/3/2006 | BT | Connetics files citizen petition for Soriatane with FDA
|
3/28/2006 | BT | SEC charges Connetics executive with insider trading
|
3/7/2006 | BT | Connetics licenses technology for treatment of hyperhidrosis
|
2/1/2006 | BT | Connetics at hold by Jefferies
|
1/11/2006 | BT | Connetics maintained by Jefferies at hold
|
1/11/2006 | CV | Market Commentary: Convertibles market remains mixed; Intel weaker; Connetics, Ford better
|
1/10/2006 | BT | Connetics buys PediaMed's sales organization
|
12/20/2005 | BT | Market Commentary: Connetics rebounds to end higher; SeraCare plunges 48%; OraSure gains 8%; CuraGen rises by 4%
|
12/20/2005 | BT | Connetics maintained by Jefferies at hold
|
11/2/2005 | BT | Jefferies maintains Connetics hold
|
10/31/2005 | BT | Jefferies reiterates Connetics at hold
|
8/18/2005 | BT | Connetics at hold by Jefferies
|
8/4/2005 | BT | Connetics price target upped by Jefferies
|
6/30/2005 | BT | Connetics initiated by Leerink Swann at outperform
|
6/30/2005 | BT | Market Commentary: Elan shares move up, credit lags, Connetics rises against the tide; Medicis, Inamed up; Millipore off
|
6/30/2005 | CV | Market Commentary: Saks, Kodak and General Mills trade in a mixed convertibles market; June marks improvements
|
6/13/2005 | CV | Market Commentary: Invitrogen launches $300 million convertible; Connetics, Cephalon stir market; Northwest hits turbulence
|
3/29/2005 | CV | Connetics greenshoe exercised, raising convertibles to $200 million
|
3/17/2005 | CV | New Issue: Connetics sells upsized $150 million convertible at 2.0%, up 35%
|
3/17/2005 | CV | Market Commentary: Cray routed by filing delay; Toys bounces on buyout; Calpine gets clobbered; Delta, FLYi plunge
|
3/16/2005 | CV | Connetics $125 million convertible talked to yield 1.5%-2.0%, up 32.5%-37.5%
|
3/16/2005 | CV | Market Commentary: GM's warning causes pile-up with Ford, Goodyear, Titan slammed; JetBlue, airlines drop on oil surge
|
8/20/2004 | CV | Market Commentary: AMR, Continental climb as oil eases; aQuantive issue goes to 102.375; Novell off on earnings
|
5/22/2003 | CV | Market Commentary: With $10 billion of new paper in play for May, flow picks up; Credence slips in overnighter
|
5/22/2003 | CV | New Issue: Connetics upsized $80 million convertibles yield 2.25%, up 35%
|
5/21/2003 | CV | Connetics prices $80 million convertibles to yield 2.25%, up 35%
|
5/21/2003 | CV | Market Commentary: Providian's new paper soars to 104.5; Elan gains on deal for King sale; new deals continue to flow
|
5/20/2003 | CV | Connetics $75 million overnighter talked at 2.25-2.75% yield, up 30-35%
|
5/20/2003 | CV | Market Commentary: Buyers finding more to chew on among this week's deals; upsizing, tightening prevail
|